A Consumer Insights Article

Most of us think of a bankruptcy as a problem for a company's investors and employees. But if you ever created an account, it's your problem too. The information you handed over doesn't vanish when the business fails. It becomes one more thing to sell.

That reality became hard to ignore in 2025, when genetic testing company 23andMe filed for Chapter 11 and millions of customers suddenly wondered who would end up owning their DNA. The answer depended less on what those customers wanted and more on a decades-old body of bankruptcy law, the company's own privacy policy, and a patchwork of state rules.

Here is how the process works, what happened in some of the most-watched cases, and what you can do before a company you trust runs into trouble.

Why Your Data Counts as an Asset

Bankruptcy exists to pay back creditors as much as possible. Customer lists, purchase histories, email addresses, and account data can be worth a lot to a buyer, so they are treated like any other property the company owns.

The main limit comes from a 2005 change to the U.S. Bankruptcy Code. Under Section 363(b)(1), a bankrupt company whose privacy policy promised not to transfer personal information can only sell that information in one of two ways:

  • The sale is consistent with the privacy policy, or
  • A court approves it after a neutral consumer privacy ombudsman reviews the deal, and the court finds the sale won't break other laws.

The ombudsman's job, set out in Section 332, is to tell the court what the privacy policy said, what customers stand to lose or gain, and what alternatives could reduce the harm. Courts often attach conditions, such as requiring the buyer to honor the old privacy policy, keep the data secure, and give customers a chance to opt out of new uses.

There is an important catch. These protections only kick in when the privacy policy in effect at filing prohibits transfers. Many policies today already say that customer data may change hands in a merger, acquisition, or bankruptcy. When that language is there, the sale can move forward with far less scrutiny.

Case Study: 23andMe and the Sale of DNA Data

23andMe sold a simple promise: send in a tube of saliva and learn where you come from and what your genes might say about your health. Behind that promise sat a vast, permanent archive of genetic profiles and stored samples. After a 2023 breach exposed data on nearly 7 million people and the business struggled to find steady revenue, the company filed for Chapter 11 in March 2025.

The auction. Regeneron Pharmaceuticals won the first round in May 2025 with a $256 million bid. The idea that a drug company could simply buy millions of genomes set off alarms, and more than two dozen states went to court arguing that DNA shouldn't be handled like ordinary inventory. When bidding reopened, TTAM Research Institute, a nonprofit formed by co-founder and former CEO Anne Wojcicki, prevailed at $305 million.

The ruling. Judge Brian Walsh approved the deal in late June 2025. His reasoning leaned on continuity: with the founder, staff, and privacy policies all carrying over, he saw the transfer as closer to a formality than a handoff to a stranger. He acknowledged the discomfort of selling genetic data but pointed out that no law forbade it. TTAM committed to preserving deletion rights and adding new safeguards.

The gaps. Continuity is not the same as consent. No customer was asked to opt in before ownership changed. The court's privacy ombudsman, Neil Richards, flagged that roughly a third of customers hadn't logged in for three years or more, so many likely never learned their data was on the auction block. About 1.9 million people did delete their accounts after the filing: a meaningful number, but still a small share of the total.

The aftermath. California kept pressing, arguing the sale ignored its genetic privacy law, which requires separate, explicit consent before DNA data or samples change hands. It lost in both the bankruptcy court and the district court. In October 2026 it reached a $6 million settlement with Chrome Holding Co., the company's successor, covering its breach claims and ending its appeal. The settlement still needs court approval.

23andMe is often described as the case where the system worked, and in one sense it did: the data didn't go to a drugmaker. But the outcome turned on who happened to bid, not on any rule guaranteeing customers a say. A different winning bidder could have produced a very different result for the same 13 million people.

Happening Now: Character.AI and Millions of Private Chats

If 23andMe raised the question of who owns the data in your body, Character.AI raises the question of who owns your inner life. Character Technologies, which runs the AI companion app, filed for Chapter 11 in Delaware in October 2026. It pointed to mounting legal bills, a path to profit that never materialized, and investors wary of lawsuits over alleged harm to young users.

What sets this case apart is the kind of data involved. People don't use companion chatbots to look things up; they confide in them. The platform reports about 12 million monthly users, at least 2 million of them minors by the company's own count. A licensing offer from Disney covers some of the technology but not user conversations, so if those chats are sold, a different buyer will be getting them.

This time, regulators are trying to get ahead of the sale instead of reacting to it. A coalition of 39 states and D.C. has asked the court to hold any buyer to a set of conditions, ranging from meaningful age checks to limits on training AI with user chats to a window for users to delete their data before the sale. The group has also raised the possibility of requesting a privacy ombudsman. California and 22 other states separately warned that the company's current voluntary safeguards could disappear under a new owner.

Two lessons from 23andMe apply directly. First, a reassuring privacy policy only protects you if the buyer is bound by it, and the company hasn't said whether that will be true here. Second, deletion has limits: once conversations have been used to train an AI model, closing an account may not undo that. Anyone who wants a copy of their chats should request an export soon, since exports can take weeks and the sale is scheduled to close by December 17.

Earlier Cases That Shaped the Rules

23andMe was not the first fight over customer data in bankruptcy. Two earlier cases set the patterns courts and regulators still follow.

Toysmart (2000). When this online toy store collapsed, its customer list was one of the few assets still worth anything, so it tried to sell it, even though it had told shoppers their information would never be shared. The FTC stepped in and treated the sale as a broken promise to consumers. States joined the fight, the list was eventually withdrawn, and an investor paid $50,000 to have it destroyed. The episode is widely seen as a driver behind the privacy protections Congress added to bankruptcy law five years later.

RadioShack (2015). Fifteen years on, the scale had exploded. The electronics retailer listed records on 117 million customers as a sellable asset, from contact details to purchase histories, again despite a promise not to sell them. Dozens of states objected, and the FTC weighed in with the court's privacy ombudsman.

The compromise approved in May 2015 shrank the data dramatically. Most records were destroyed. The buyer received only email addresses that had been active recently, customers got a chance to opt out, and the buyer had to honor the old policy and keep the list to itself.

Put these cases side by side and a few questions emerge that anyone can use to judge whether a data sale treats customers fairly:

  • Is the data staying with a business similar to the one customers signed up for?
  • Is the buyer held to the promises customers were originally given?
  • Do customers get a real choice before their data is used in new ways?
  • Is data the buyer doesn't need being deleted rather than passed along?

What Actually Protects You

Your protection in a bankruptcy rests on a few overlapping layers, and none of them is airtight.

The privacy policy. This is the single biggest factor. If a company promised not to transfer your data, the Bankruptcy Code's ombudsman process kicks in. If the policy already allows transfers in a sale or bankruptcy, there is much less standing in the way.

Federal regulators. The FTC can treat a sale that breaks a company's privacy promises as a deceptive practice, as it did with Toysmart and RadioShack.

State laws and attorneys general. States have been the most active defenders of customers in recent cases. Some, like California, have genetic privacy laws that require explicit consent before DNA data is transferred. But as 23andMe showed, a bankruptcy court can still approve a sale over those objections. Many state privacy laws also give residents the right to request deletion.

What's missing. Federal bankruptcy law's definition of personal information does not specifically cover genetic data, and health privacy law HIPAA generally doesn't apply to consumer DNA kits. In response to 23andMe, a bipartisan group in Congress introduced the Don't Sell My DNA Act in 2025. It would add genetic information to the Bankruptcy Code's protected categories and require written notice and opt-in consent before it could be sold (Senate Judiciary Committee; American Bar Association). As of this writing, the bill had not become law; check Congress.gov for its current status.

What You Can Do

The most reliable protection is the data a company never holds, or no longer holds. A few habits go a long way:

  • Read the transfer clause. Before signing up, search a privacy policy for words like "merger," "acquisition," "bankruptcy," or "sale of assets." That section tells you what happens to your data if the company is sold.
  • Share only what's needed. Skip optional fields, and think twice before handing over data you can't change, like DNA or biometrics.
  • Delete dormant accounts. A third of 23andMe customers hadn't logged in for years when the sale happened. Accounts you no longer use are data you no longer need a company to keep.
  • Watch the news for companies you use. A bankruptcy filing is your cue to download what you want and request deletion before any sale closes. Deleted data won't transfer to a buyer, though data already used in completed research may not be removable.
  • Withdraw consents you don't want. Many services let you opt out of research or marketing uses in account settings, separate from full deletion.
  • Use your state rights. If your state gives you a right to delete, use it. Your attorney general's office often posts step-by-step instructions, as California did for 23andMe.

When a company fails, its promises to you are only as strong as the words in its privacy policy and the people willing to enforce them. 23andMe showed both the strength and the limits of today's system: regulators, states, and an ombudsman shaped the deal, yet millions of people's genetic data still moved to a new owner without their explicit consent.

Until the law catches up, the practical lesson is simple. Know what you've shared, know what the company is allowed to do with it, and act early when a company you trust starts to struggle.